Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. E-pub ahead of print
  3. Published

    Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

    Sørensen, A. L., Mikkelsen, S. U., Knudsen, T. A., Bjørn, M. E., Andersen, C. L., Bjerrum, O. W., Brochmann, N., Patel, D. A., Gjerdrum, L. M. R., El Fassi, D., Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Ellervik, C., Pallisgaard, N., Thomassen, M., Kjær, L., Skov, V. & Hasselbalch, H. C., 1 Sep 2020, In : Haematologica. 105, 9, p. 2262-2272 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2019
  5. Published

    Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy

    Nardo-Marino, A., Bukan, K., Nielsen, H. V. & El Fassi, D., 20 Aug 2019, In : Br J Rheumatol. 6, 4, p. 226-227 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published
  7. Published

    Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

    Bukan, K. B., Nardo-Marino, A., Hagdrup, C., Boennelycke, M., Breinholdt, M. F., Schöllkopf, C., Nielsen, H. V. & El Fassi, D., 2019, In : Scandinavian Journal of Rheumatology. 48, 4, p. 342-343 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

  8. 2018
  9. Published

    Eosinofili

    Bjerrum, O. W., Fassi, D. E., Madsen, G., Stentoft, J., Vestergaard, H., Rønnov-Jessen, D., Pedersen, P. T., Pulczynski, S., Overgaard, U. M. & Andersen, C. L., 10 Sep 2018, In : Ugeskrift for Laeger. 180, 37, p. V01180032

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis

    Mikkelsen, S. U., Kjaer, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Andersen, C. B. L., Bjerrum, O. W., Brochmann, N., Fassi, D. E., Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Pallisgaard, N., Thomassen, M., Skov, V. & Hasselbalch, H. C., Aug 2018, In : Cancer Medicine. 7, 8, p. 3571-3581 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Multicentrisk retikulohistiocytose er en sjælden form for paraneoplasi

    Anderson, A. M., Todberg, T., Kofoed, K., Iversen, T. Z., Andersen, M., Hjorth, S. V. & Fassi, D. E., 1 Jan 2018, In : Ugeskrift for Laeger. 180, p. 2-3 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. 2015
  13. Published

    Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis

    El Fassi, D., 24 Dec 2015, In : The New England journal of medicine. 373, 26, p. 2579

    Research output: Contribution to journalComment/debateResearchpeer-review

  14. 2013
  15. Published

    Hyperkalemia: a clue to the diagnosis of adrenal insufficiency

    El Fassi, D. & Nielsen, G. A., 17 Dec 2013, In : Circulation (Baltimore). 128, 24, p. 2620-1 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2012
  17. Published

    Anti-CD20 antibody therapy for B-cell lymphomas

    El Fassi, D., Hegedüs, L. & Nielsen, C. H., 2012, In : New England Journal of Medicine. 367, 9, p. 877; author reply 878

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Behandling af metforminassocieret laktatacidose med hæmodialyse

    Schousboe, K., El Fassi, D., Secher, E. L., Elming, H., Rasmussen, K. & Hornum, M., 2012, In : Ugeskrift for Laeger. 174, 23, p. 1604-6 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Ulcerative colitis

    El Fassi, D. & Nielsen, C. H., 2012, In : New England Journal of Medicine. 366, 9, p. 862; author reply 862-3

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. 2011
  21. Published

    Systemic adverse events following rituximab therapy in patients with Graves' disease

    El Fassi, D., Nielsen, C. H., Junker, M. P., Hasselbalch, H. C. & Hegedüs, L., 2011, In : Journal of Endocrinological Investigation. 34, 7, p. e163-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. 2009
  23. Published

    Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy

    Nielsen, J. F., El Fassi, D., Nielsen, C. H., Hegedüs, L., Lauer, S. A., Silkiss, R. Z. & Prause, J. U., 1 Nov 2009, In : Acta Ophthamologica (Online). 87, 8, p. 927-9 3 p.

    Research output: Contribution to journalJournal articleResearch

  24. Published

    Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies

    El Fassi, D., Banga, J. P., Gilbert, J. A., Padoa, C., Hegedüs, L. & Nielsen, C. H., 1 Mar 2009, In : Clinical Immunology. 130, 3, p. 252-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. 2008
  26. Published

    Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials

    Banga, J. P., Nielsen, C. H., Gilbert, J. A., El Fassi, D. & Hegedus, L., 1 Sep 2008, In : Thyroid : official journal of the American Thyroid Association. 18, 9, p. 973-81 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Biologiske behandlingsmuligheder ved Graves' oftalmopati

    El Fassi, D., Nielsen, C. H. & Hegedüs, L., 9 Jun 2008, In : Ugeskrift for Laeger. 170, 24, p. 2128-30 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Nye behandlinger af Graves' sygdom med fokus på det B-lymfocyt-depleterende antistof rituximab

    Nielsen, C. H., El Fassi, D. & Hegedüs, L., 9 Jun 2008, In : Ugeskrift for Laeger. 170, 24, p. 2131-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease

    El Fassi, D., Nielsen, C. H., Kjeldsen, J. B., Clemmensen, O. & Hegedüs, L., 1 May 2008, In : Gut. 57, 5, p. 714-5 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. 2007
  31. Published

    Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease

    El Fassi, D., Clemmensen, O., Nielsen, C. H., Silkiss, R. Z. & Hegedüs, L., 1 Oct 2007, In : Journal of Clinical Endocrinology and Metabolism. 92, 10, p. 3762-3 2 p.

    Research output: Contribution to journalJournal articleResearch

  32. Published

    B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family

    Nielsen, C. H., El Fassi, D., Hasselbalch, H. K., Bendtzen, K. & Hegedüs, L., 1 Jul 2007, In : Expert Opinion on Biological Therapy. 7, 7, p. 1061-78 18 p.

    Research output: Contribution to journalJournal articleResearch

  33. Published

    B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study

    El Fassi, D., Nielsen, C. H., Bonnema, S. J., Hasselbalch, H. K. & Hegedüs, L., 1 May 2007, In : Journal of Clinical Endocrinology and Metabolism. 92, 5, p. 1769-72 4 p.

    Research output: Contribution to journalJournal articleResearch

  34. 2006
  35. Published

    Rituximab (MabThera) til behandling af aktiv reumatoid artritis

    El Fassi, D., Nielsen, C. H. & Bendtzen, K., 20 Nov 2006, In : Ugeskrift for Laeger. 168, 47, p. 4079-81 3 p.

    Research output: Contribution to journalJournal articleResearch

  36. Published

    Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion

    El Fassi, D., Nielsen, C. H., Hasselbalch, H. K. & Hegedüs, L., 1 Jul 2006, In : Thyroid. 16, 7, p. 709-10 2 p.

    Research output: Contribution to journalJournal articleResearch

  37. Published

    The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option

    El Fassi, D., Nielsen, C. H., Hasselbalch, H. K. & Hegedüs, L., 1 May 2006, In : European Journal of Endocrinology. 154, 5, p. 623-32 10 p.

    Research output: Contribution to journalJournal articleResearch

ID: 45970477